Literature DB >> 18029365

Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study.

Johann Christoph Geller1, Sven Cassens, Mathias Brosz, Ulrich Keil, Johannes Bernarding, Siegfried Kropf, Ralph A Bierwirth, Bernhard Lippmann-Grob, Heinz-Peter Schultheiss, Klaus Schlüter, Klaus Pels.   

Abstract

AIMS: The success in achieving treatment goals for cardiovascular risk factors in primary care is largely unknown. Therefore, the goals of this study were (i) to assess whether routinely collected practice data can be used to evaluate treatment in primary care, (ii) to compare current treatment with goals of published guidelines, and (iii) to calculate future risk for cardiovascular events using these real-life data. METHODS AND
RESULTS: In 110 physician offices in Germany, data from the patient management systems of all patients seen between January 1998 and June 2005 were extracted and analysed (715 644) with current guidelines used for reference. Of those patents, 284 096 (40% of all patients analysed) had one of the following diseases: 157 101 (55% of 284 096) had hypertension, 83 005 (29%) diabetes, 64 205 (23%) coronary artery disease (CAD), 174 787 (62%) hyperlipidaemia, and 136 360 (48%) had more than one of the listed diagnoses. During the last visit, treatment goals were achieved for total and LDL cholesterol in 9 and 29%, respectively, for blood pressure in 28%, and for HbA1c in 36%. Low achievement of treatment goals was also seen in patients with CAD or diabetes. Using the Framingham risk model and the SCORE Deutschland risk charts, 20 and 22% of patients had a high 10-year risk for a primary cardiovascular event and a fatal cardiovascular event, respectively. Achieving treatment goals for all risk factors would significantly reduce the number of high-risk patients.
CONCLUSION: (i) Routinely collected practice data can be used to evaluate quality of care; (ii) 40% of patients in primary care have cardiovascular disease or diabetes; (iii) even in high-risk patients, the majority does not achieve treatment goals; and (iv) achieving the treatment goals would reduce the proportion of high-risk patients from 20 to <5%.

Entities:  

Mesh:

Year:  2007        PMID: 18029365     DOI: 10.1093/eurheartj/ehm520

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Sex and gender differences in health. Science & Society Series on Sex and Science.

Authors:  Vera Regitz-Zagrosek
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

2.  Physicians' knowledge of and compliance with guidelines: an exploratory study in cardiovascular diseases.

Authors:  Ute Karbach; Ingrid Schubert; Jens Hagemeister; Nicole Ernstmann; Holger Pfaff; Hans-Wilhelm Höpp
Journal:  Dtsch Arztebl Int       Date:  2011-02-04       Impact factor: 5.594

3.  The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan.

Authors:  Linda Tahaineh; Abla Albsoul-Younes; Eman Al-Ashqar; Ala Habeb
Journal:  Int J Clin Pharm       Date:  2011-01-28

4.  Blood pressure management in a cohort of hypertensive patients in Germany treated by cardiologists.

Authors:  Martin Thoenes; Ulrich Tebbe; Ludger Rosin; W Dieter Paar; Peter Bramlage; Wilhelm Kirch; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2011-01-05       Impact factor: 5.460

5.  Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care.

Authors:  Frederic Kontny; Terje Risanger; Arne Bye; Øyvind Arnesen; Odd Erik Johansen
Journal:  Vasc Health Risk Manag       Date:  2010-02-04

6.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.

Authors:  José R Banegas; Esther López-García; Jean Dallongeville; Eliseo Guallar; Julian P Halcox; Claudio Borghi; Elvira L Massó-González; Francisco J Jiménez; Joep Perk; Philippe Gabriel Steg; Guy De Backer; Fernando Rodríguez-Artalejo
Journal:  Eur Heart J       Date:  2011-04-06       Impact factor: 29.983

7.  From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial.

Authors:  Achim Mortsiefer; Tobias Meysen; Martin Schumacher; Heinz-Harald Abholz; Karl Wegscheider; Jürgen In der Schmitten
Journal:  BMC Fam Pract       Date:  2015-05-07       Impact factor: 2.497

8.  Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997-1999 and 2008-2011.

Authors:  Yong Du; Christin Heidemann; Angelika Schaffrath Rosario; Amanda Buttery; Rebecca Paprott; Hannelore Neuhauser; Thea Riedel; Andrea Icks; Christa Scheidt-Nave
Journal:  BMJ Open Diabetes Res Care       Date:  2015-11-19

9.  Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.

Authors:  Theresa Tiffe; Martin Wagner; Viktoria Rücker; Caroline Morbach; Götz Gelbrich; Stefan Störk; Peter U Heuschmann
Journal:  BMC Cardiovasc Disord       Date:  2017-11-02       Impact factor: 2.298

10.  Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis.

Authors:  Barbara Bohn; Christof Schöfl; Vincent Zimmer; Michael Hummel; Nikolai Heise; Erhard Siegel; Wolfram Karges; Michaela Riedl; Reinhard W Holl
Journal:  Cardiovasc Diabetol       Date:  2016-05-03       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.